These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1310988)

  • 1. Inhibition of T cell antigen receptor-dependent phosphorylation of CD4 in human immunodeficiency virus type 1 infected cells.
    Gaulton GN; Brass LF; Kozbor D; Pletcher CH; Hoxie JA
    J Biol Chem; 1992 Feb; 267(6):4102-9. PubMed ID: 1310988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway.
    Cefai D; Debre P; Kaczorek M; Idziorek T; Autran B; Bismuth G
    J Clin Invest; 1990 Dec; 86(6):2117-24. PubMed ID: 1979339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal T cell receptor-mediated signaling in T cell lines stably expressing HIV-1 envelope glycoproteins.
    Tani Y; Tian H; Lane HC; Cohen DI
    J Immunol; 1993 Dec; 151(12):7337-48. PubMed ID: 7903106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD3-zeta surface expression is required for CD4-p56lck-mediated upregulation of T cell antigen receptor-CD3 signaling in T cells.
    Sancho J; Ledbetter JA; Choi MS; Kanner SB; Deans JP; Terhorst C
    J Biol Chem; 1992 Apr; 267(11):7871-9. PubMed ID: 1532798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 envelope glycoproteins induce activation of activated protein-1 in CD4+ T cells.
    Chirmule N; Goonewardena H; Pahwa S; Pasieka R; Kalyanaraman VS; Pahwa S
    J Biol Chem; 1995 Aug; 270(33):19364-9. PubMed ID: 7642615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity.
    Page KA; Stearns SM; Littman DR
    J Virol; 1992 Jan; 66(1):524-33. PubMed ID: 1727497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1.
    Bour S; Boulerice F; Wainberg MA
    J Virol; 1991 Dec; 65(12):6387-96. PubMed ID: 1942241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of CD4+ T cell activation and adhesion by peptides derived from the gp160.
    Corado J; Mazerolles F; Le Deist F; Barbat C; Kaczorek M; Fischer A
    J Immunol; 1991 Jul; 147(2):475-82. PubMed ID: 1677023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced in vitro human immunodeficiency virus type 1 replication in B cells expressing surface antibody to the TM Env protein.
    Tani Y; Donoghue E; Sharpe S; Boone E; Lane HC; Zolla-Pazner S; Cohen DI
    J Virol; 1994 Mar; 68(3):1942-50. PubMed ID: 8107254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4 and CD8 T cells from SIV-infected macaques have defective signaling responses after perturbation of either CD3 or CD2 receptors.
    Gale MJ; Ledbetter JA; Schieven GL; Jonker M; Morton WR; Benveniste RE; Clark EA
    Int Immunol; 1990; 2(9):849-58. PubMed ID: 1980619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccinia virus vectors for study of membrane fusion mediated by human immunodeficiency virus envelope glycoprotein and CD4.
    Ashorn P; Berger EA; Moss B
    Methods Enzymol; 1993; 221():12-8. PubMed ID: 8361369
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression and characterization of a functional human immunodeficiency virus envelope glycoprotein in insect cells.
    Wells DE; Compans RW
    Virology; 1990 Jun; 176(2):575-86. PubMed ID: 2111957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of viral activation in a CD4+ cell model of chronic infection.
    Butera ST; Perez VL; Wu BY; Nabel GJ; Folks TM
    J Virol; 1991 Sep; 65(9):4645-53. PubMed ID: 1678437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of human immunodeficiency virus glycoprotein 160 with CD4 in Jurkat cells increases p56lck autophosphorylation and kinase activity.
    Soula M; Fagard R; Fischer S
    Int Immunol; 1992 Feb; 4(2):295-9. PubMed ID: 1535787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface expression of the HIV-1 envelope proteins in env gene-transfected CD4-positive human T cell clones: characterization and killing by an antibody-dependent cellular cytotoxic mechanism.
    Ahmad A; Yao XA; Tanner JE; Cohen E; Menezes J
    J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):789-98. PubMed ID: 7912729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early activation events render T cells susceptible to HIV-1-induced syncytia formation. Role of protein kinase C.
    Mohagheghpour N; Chakrabarti R; Stein BS; Gowda SD; Engleman EG
    J Biol Chem; 1991 Apr; 266(11):7233-8. PubMed ID: 1826686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus gp120 and derived peptides activate protein tyrosine kinase p56lck in human CD4 T lymphocytes.
    Hivroz C; Mazerolles F; Soula M; Fagard R; Graton S; Meloche S; Sekaly RP; Fischer A
    Eur J Immunol; 1993 Mar; 23(3):600-7. PubMed ID: 7680610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes.
    Willey RL; Maldarelli F; Martin MA; Strebel K
    J Virol; 1992 Jan; 66(1):226-34. PubMed ID: 1727486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1.
    Kalyanaraman VS; Rodriguez V; Veronese F; Rahman R; Lusso P; DeVico AL; Copeland T; Oroszlan S; Gallo RC; Sarngadharan MG
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):371-80. PubMed ID: 2187500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 down-regulates CD4 costimulation of TCR/CD3-directed tyrosine phosphorylation through CD4/p56lck dissociation.
    Kanner SB; Haffar OK
    J Immunol; 1995 Mar; 154(6):2996-3005. PubMed ID: 7876562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.